You are here
FDA to consider approval of new class of cholesterol drugs
A FEDERAL advisory committee this week will decide whether to recommend approval of the first in a new class of drugs that many experts believe could significantly cut the risk of strokes and heart attacks, a leading cause of death for Americans.
The highly anticipated
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org